← Home
Making Sense with Sam Harris · July 14, 2026 · 1h 21m

#485 — The New Science of Cancer

Sam Harris speaks with oncologist and author Siddhartha Mukherjee about the latest cancer science and the updated edition of his landmark book The Emperor of All Maladies. They explore whether cancer is one disease or many, why prevention remains elusive despite our knowledge, the role of inflammation and air pollution as carcinogens, debunk the cell phone cancer myth, discuss liquid biopsies and Bayesian reasoning in diagnosis, examine immunotherapy breakthroughs like CAR T cells, and consider AI's potential in drug discovery and the structural problems in American medical pricing.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Curious

Despite decades of evidence about cancer risk factors (smoking, diet, exercise, alcohol), population-level behavior hasn't shifted proportionally—knowledge alone doesn't drive behavior change.
AI's Promise and the Clinical Translation Bottleneck in Drug Discovery
While AI excels at identifying candidate compounds and optimizing molecular structures, the bottleneck in drug development remains clinical translation—moving from promising lab results to approved therapies.

Novel

Liquid Biopsies and Early Detection via Blood Tests
Liquid biopsies—blood tests that detect circulating tumor DNA—offer the potential for earlier cancer detection and monitoring without invasive tissue sampling, though clinical application is still developing.

Highlights

Cancer as a Disease of Evolution and Competition
Cancer is fundamentally a disease of uncontrolled cellular evolution—mutant cells competing and adapting within the body in ways that override normal growth constraints.
Chronic inflammation and air pollution are significant but often overlooked drivers of cancer risk, operating through oxidative stress and cellular damage that can persist for years.
CAR T Cells: Programming the Immune System as a Drug
CAR T cell immunotherapy represents a paradigm shift—extracting patient immune cells, genetically engineering them to recognize cancer, and returning them as a living drug.

Editorial

Cancer as One Disease or Many
Mukherjee explores whether cancer should be understood as a single disease with shared principles or as hundreds of distinct diseases, each requiring specific approaches.

Contradicts

The Cell Phone Cancer Myth
Despite decades of public concern, high-quality evidence does not support a causal link between cell phone radiation and cancer.

References

The Emperor of All Maladies: A Biography of CancerSiddhartha Mukherjee (2010)Updated edition discussed; foundational text on cancer history and science

Misc

Mukherjee emphasizes cancer as fundamentally a disease of evolution and competition within cells
Discussion of how individual cancer prevention knowledge doesn't translate to population-level behavior change
CAR T cell immunotherapy represents a paradigm shift—using the immune system as a programmable drug
Tension between the drug discovery promise of AI and the actual bottleneck in clinical translation
Was this useful?